October 19, 2015 | German dialysis company Fresenius Medical Care has acquired the Nephromor chain of community dialysis centers, owned by Israeli pharmaceutical giant Teva and Israeli healthcare service provider Clalit, Globes reports. The sale price is estimated to be between $70 and $90 million. Founded in 1994, Nephromor provides dialysis services – a life-support treatment that supports the functioning of impaired kidneys.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments